Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

re, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

This press release and/or the financial results attached to this press release include "Adjusted Net Income," "Basic Adjusted Income per Common Share," "Basic Adjusted Income per Common Share Guidance," and "Diluted Adjusted Income Per Common Share," amounts that are considered "non-GAAP financial measures" under SEC rules. As required, we have provided reconciliations of these measures. Additional required information is located in the Form 8-K furnished to the SEC in connection with this press release.

CEPHALON, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

REVENUES:

Sales $428,729 $470,513 $1,287,802 $1,246,825

Other revenues 9,692 11,820 34,865 32,562

438,421 482,333 1,322,667 1,279,387

COSTS AND EXPENSES:

Cost of sales 82,258 83,160 251,970 250,613

Research and development 93,527 86,439 274,078 294,899

Selling, general and

administrative 186,456 161,108 527,962 470,158

Settlement reserve 369,000 - 425,000 -

Impairment charge - - - 12,417

731,241 330,707 1,479,010 1,028,087

INCOME (LOSS) FROM OPERATIONS (292,820) 15
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... E-QURE Corp. (OTCQB: EQUR), a ... Signal Therapy device ("BST Device"), a new and novel ... chronic wounds, today announced that the Company has signed ... specializing in medical devices, for the marketing and distribution ... 70 years old, sales, marketing and distribution company in ...
(Date:8/3/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a ... autologous cell therapies, announced today that RepliCel,s CEO, David ... in Minneapolis, Minnesota on August 5 ... highlight RepliCel,s 18-month milestones including CE Mark for its RCI-02 ... clinical data from both RCT-01 (tendon) and RCS-01 (skin) clinical ...
(Date:7/31/2015)... Dallas, Texas (PRWEB) , ... July 31, 2015 ... ... research report, offering competitive market analysis and premium industry insights on the global ... challenges, based on a collective study of vivid market scenarios and analysis of ...
(Date:7/30/2015)... ... 2015 , ... Ralco is honored to announce that it is the primary ... held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where ... impacts their daily lives. This unique exhibit also features a birthing center for fair ...
Breaking Biology Technology:E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2
... Technologies, Inc. (NYSE Amex: PTN ) announced that ... Growth Stock Conference on Tuesday, March 13, 2012, at 1:30 ... Ritz Carlton Laguna Niguel in Dana Point, CA. ... Palatin Technologies, will provide an update on Palatin,s corporate and ...
... AUSTIN, Texas, March 6, 2012  The nonprofit American Botanical Council ... Literature Award in the newly designated consumer and popular books ... Exotic Spices to Boost Health and Beat Disease . The ... and Debora Yost, and published by Sterling Publishing in 2011. ...
... have developed a self-healing hydrogel that binds in seconds, ... enough to withstand repeated stretching. The material has numerous ... sealants and self-healing plastics, a team of UC San ... in the online Early Edition of the Proceedings ...
Cached Biology Technology:Healing Spices Book Receives ABC's Duke Award for Consumer and Popular Books Category 2Healing Spices Book Receives ABC's Duke Award for Consumer and Popular Books Category 3Healing Spices Book Receives ABC's Duke Award for Consumer and Popular Books Category 4Smart, self-healing hydrogels open far-reaching possibilities in medicine, engineering 2
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/km7m5t/natural_language ... "Natural Language Processing Market by Type (Rule-Based, Statistical, ... Image Recognition) - Worldwide Forecast to 2020" ... vendors occupying the market are 3M, Apple, Dolbey ... Solutions, SAS Institute Inc., Verint Systems among various ...
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) has ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Biomedical Sensors market is estimated at $0.65 billion by ... 2014-2020 The near future will bring Biomedical ... each individual. These sensors can be set to trigger ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... of American Societies for Experimental Biology (FASEB) announces ... Conference (SRC): Genetic Recombination & Genome Rearrangements. ... Recombination & Genome Rearrangements convenes leading researchers focusing ... systems in the study of recombination. Recombination is ...
... MD The Federation of American Societies for ... for the Science Research Conference (SRC): Glucose transport: ... FASEB Science Research Conference "Glucose transport: Gateway for ... the role of glucose transport in the control ...
... University research, part of a healthy diet can include ... Drouillard, professor of animal sciences and industry, developed a ... -- fatty acids that have been shown to reduce ... ground beef is named GreatO Premium Ground Beef and ...
Cached Biology News:University-developed omega-3-rich ground beef available soon 2University-developed omega-3-rich ground beef available soon 3
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
Mouse monoclonal antibody to ANAPC2 - anaphase promoting complex subunit 2...
... The MAX POWER 500V Programmable Power ... instruments which can handle virtually any ... high current blotting. It is unique ... displays. The MAX POWER Programmable Power ...
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
Biology Products: